Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of GHRL mRNA | increases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GHRL mRNA | affects expression | 16483693
|
C120841 |
astressin B |
astressin B inhibits the reaction [GHRL protein results in decreased expression of LHB protein] | decreases expression|decreases reaction | 18063681
|
C120841 |
astressin B |
astressin B inhibits the reaction [GHRL protein results in increased abundance of Hydrocortisone] | decreases reaction|increases abundance | 18063681
|
D001285 |
Atropine |
Atropine inhibits the reaction [[Pentobarbital co-treated with L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide] results in increased expression of GHRL protein] | affects cotreatment|decreases reaction|increases expression | 16959836
|
D002211 |
Capsaicin |
GHRL protein inhibits the reaction [Capsaicin results in increased expression of FOS protein] | decreases reaction|increases expression | 18202139
|
C103490 |
dexloxiglumide |
dexloxiglumide inhibits the reaction [osteum results in decreased expression of GHRL protein] | decreases expression|decreases reaction | 17138722
|
D004298 |
Dopamine |
GHRL protein results in decreased export of Dopamine | decreases export | 20553917
|
D004317 |
Doxorubicin |
GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 mRNA] | decreases expression|decreases reaction | 18400355
|
D004317 |
Doxorubicin |
GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18400355
|
D004317 |
Doxorubicin |
GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] | decreases expression|decreases reaction | 18400355
|
D004317 |
Doxorubicin |
GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of TNF protein] | decreases expression|decreases reaction | 18400355
|
D004317 |
Doxorubicin |
GHRL protein promotes the reaction [Doxorubicin results in increased localization of and results in increased activity of RELA protein] | increases activity|increases localization|increases reaction | 18400355
|
D004317 |
Doxorubicin |
TNF protein affects the reaction [GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 mRNA]] | affects reaction|decreases expression|decreases reaction | 18400355
|
D004317 |
Doxorubicin |
TNF protein affects the reaction [GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]] | affects reaction|decreases expression|decreases reaction | 18400355
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of GHRL mRNA | decreases expression | 18035473
|
D005632 |
Fructose |
Fructose results in increased expression of GHRL protein | increases expression | 18627777
|
D006854 |
Hydrocortisone |
astressin B inhibits the reaction [GHRL protein results in increased abundance of Hydrocortisone] | decreases reaction|increases abundance | 18063681
|
D006854 |
Hydrocortisone |
GHRL protein results in increased abundance of Hydrocortisone | increases abundance | 18063681
|
D012701 |
Serotonin |
GHRL protein results in decreased export of Serotonin | decreases export | 20553917
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [Lipopolysaccharides affects the expression of GHRL protein] | affects expression|decreases reaction | 16959954
|
D008070 |
Lipopolysaccharides |
IL1B protein affects the reaction [Lipopolysaccharides affects the expression of GHRL protein] | affects expression|affects reaction | 16959954
|
D008070 |
Lipopolysaccharides |
IL1RN protein inhibits the reaction [Lipopolysaccharides affects the expression of GHRL protein] | affects expression|decreases reaction | 16959954
|
D008070 |
Lipopolysaccharides |
Indomethacin inhibits the reaction [Lipopolysaccharides affects the expression of GHRL protein] | affects expression|decreases reaction | 16959954
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides affects the expression of GHRL protein | affects expression | 16959954
|
C027979 |
L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide |
Atropine inhibits the reaction [[Pentobarbital co-treated with L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide] results in increased expression of GHRL protein] | affects cotreatment|decreases reaction|increases expression | 16959836
|
C027979 |
L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide |
[Pentobarbital co-treated with L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide] results in increased expression of GHRL protein | affects cotreatment|increases expression | 16959836
|
D009599 |
Nitroprusside |
GHRL protein inhibits the reaction [Nitroprusside results in increased cleavage of and results in increased activity of CASP3 protein] | decreases reaction|increases activity|increases cleavage | 17543279
|
D009599 |
Nitroprusside |
GHRL protein inhibits the reaction [Nitroprusside results in increased phosphorylation of and results in increased activity of MAP3K5 protein] | decreases reaction|increases activity|increases phosphorylation | 17543279
|
D009599 |
Nitroprusside |
Quercetin inhibits the reaction [GHRL protein inhibits the reaction [Nitroprusside results in increased expression of MAP3K5 protein]] | decreases reaction|increases expression | 17543279
|
C042763 |
olive oil |
olive oil results in decreased expression of GHRL protein | decreases expression | 17138722
|
C042763 |
olive oil |
orlistat inhibits the reaction [olive oil results in decreased expression of GHRL protein] | decreases expression|decreases reaction | 17138722
|
C055122 |
orlistat |
orlistat inhibits the reaction [olive oil results in decreased expression of GHRL protein] | decreases expression|decreases reaction | 17138722
|
C013173 |
osteum |
dexloxiglumide inhibits the reaction [osteum results in decreased expression of GHRL protein] | decreases expression|decreases reaction | 17138722
|
C013173 |
osteum |
osteum results in decreased expression of GHRL protein | decreases expression | 17138722
|
D010424 |
Pentobarbital |
Atropine inhibits the reaction [[Pentobarbital co-treated with L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide] results in increased expression of GHRL protein] | affects cotreatment|decreases reaction|increases expression | 16959836
|
D010424 |
Pentobarbital |
[Pentobarbital co-treated with L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide] results in increased expression of GHRL protein | affects cotreatment|increases expression | 16959836
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [GHRL protein inhibits the reaction [Nitroprusside results in increased expression of MAP3K5 protein]] | decreases reaction|increases expression | 17543279
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of GHRL mRNA | increases expression | 17350061
|
D013311 |
Streptozocin |
GHRL protein promotes the reaction [Streptozocin results in decreased expression of CARTPT mRNA] | decreases expression|increases reaction | 20219977
|
D013311 |
Streptozocin |
GHRL protein promotes the reaction [Streptozocin results in decreased expression of FASN mRNA] | decreases expression|increases reaction | 20219977
|
D013311 |
Streptozocin |
GHRL protein promotes the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA] | decreases expression|increases reaction | 20219977
|
D013549 |
Sweetening Agents |
Sweetening Agents results in increased expression of GHRL protein | increases expression | 18627777
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
4.36 | 18926900 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.39 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
4.39 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.87 | 18653653 11850527 |
MESH:D000230 |
Adenocarcinoma |
marker/mechanism |
|
| 21472143 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.60 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
4.60 | 16537180 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.56 | 3712494 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
6.56 | 11497255 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.53 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.73 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.38 | 21441931 |
MESH:D000505 |
Alopecia |
|
astressin B |
9.96 | 21359208 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
9.96 | 17569567 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
5.20 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
2.67 | 17627676 15579461 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.08 | 17084956 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
4.59 | 11141031 18313124 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.68 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
4.70 | 10388637 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
5.00 | 2160914 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
2.78 | 11248219 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.80 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
olive oil |
4.24 | 16216721 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
3.48 | 18405062 18361446 15132762 19221690 8570775 17157402 18062943 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.24 | 19761891 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.81 | 10684365 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.85 | 11289319 1440618 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.53 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
10.68 | 18207255 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
10.68 | 8112388 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.85 | 11481608 |
MESH:D001930 |
Brain Injuries |
|
Nitroprusside |
5.52 | 14637104 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
10.03 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
10.03 | 12524144 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.66 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Atropine |
2.09 | 12762645 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.09 | 17426702 18628466 16595493 16264153 15634643 15939500 16826403 18695136 15567936 15136595 17369602 16096432 16935488 19526202 16115903 15993339 15994142 18382427 15668708 11325840 15692762 16322301 18234424 17983394 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
2.09 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
2.09 | 18628248 |
MESH:D019121 |
Burkholderia Infections |
|
orlistat |
6.47 | 17874328 |
MESH:D002056 |
Burns |
|
Indomethacin |
4.53 | 10459503 |
MESH:D002100 |
Cachexia |
therapeutic |
|
| 17347304 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.83 | 15141370 16537180 11239499 15625704 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.37 | 16962696 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.12 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
12.12 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.59 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.59 | 18059187 16023760 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
8.59 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
8.59 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.59 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
4.55 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
5.18 | 14736730 11352223 18791128 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.78 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
10.37 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.37 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
10.37 | 17341418 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.37 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
7.37 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.37 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
3.22 | 19794523 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.42 | 16455267 17308081 16242529 18627295 16612575 16731534 17928571 16269455 16278810 17329180 16952015 17351982 17974986 17519947 17924179 15476868 17007740 16651473 16109756 17131338 15505089 16364871 17382496 15811867 15792986 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.89 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
olive oil |
4.42 | 16216721 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.35 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.35 | 20056578 19524636 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
4.10 | 21254450 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
5.00 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.02 | 19486331 9022650 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.52 | 17157402 |
MESH:D002916 |
Chylothorax |
|
orlistat |
6.47 | 17003701 |
MESH:D002972 |
Cleft Palate |
|
Hydrocortisone |
4.08 | 15826874 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
3.92 | 11260862 15786552 15936596 15625704 15637740 15963497 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
3.92 | 19440933 19056647 17148506 11134977 16640504 17191121 15741050 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.48 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
3.48 | 11197048 17054584 12606626 18059344 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.48 | 18852136 18095365 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
4.37 | 18504504 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.54 | 17302372 |
MESH:D003371 |
Cough |
|
Capsaicin |
5.00 | 10350223 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Hydrocortisone |
3.29 | 17728286 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.64 | 8156756 11906362 12868966 14531868 18759878 2524372 8970840 11298694 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.33 | 3621924 2952479 |
MESH:D048909 |
Diabetes Complications |
|
orlistat |
5.66 | 19207292 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.58 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
13.40 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
13.40 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
13.40 | 19586609 19960420 12446591 18603373 12083368 16286809 2177838 16684804 11260395 15298345 17874149 8740154 17442507 15862027 15831366 7637645 12093613 19496084 1374869 12644472 11055810 6379147 18715473 19298542 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
3.58 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
5.14 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
5.14 | 19586609 19647726 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.55 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
4.53 | 19682444 19960420 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.26 | 17662242 |
MESH:D003967 |
Diarrhea |
|
Atropine |
23.11 | 10867622 |
MESH:D003967 |
Diarrhea |
|
Hydrocortisone |
23.11 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
23.11 | 7237001 7907874 |
MESH:D003967 |
Diarrhea |
|
orlistat |
23.11 | 20002075 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
23.11 | 11488427 8112388 10446763 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
3.86 | 18289764 7440962 18692083 6482804 18648102 8291058 9653073 11289319 6679447 9022650 1440618 9328219 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.86 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.54 | 18602426 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.98 | 18446180 16326151 17190690 16133044 12774134 18043480 |
MESH:D004381 |
Duodenal Ulcer |
|
Atropine |
14.72 | 11595415 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
14.72 | 11535926 10671773 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
14.72 | 17045617 17351913 17151854 11595415 17329845 10671773 11535926 11595431 11991626 17202747 16699067 |
MESH:D004487 |
Edema |
|
Indomethacin |
7.17 | 7907874 19703484 16100529 10653021 7990266 8985016 8273558 |
MESH:D004487 |
Edema |
|
Serotonin |
7.17 | 18841975 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.34 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
3.99 | 15652904 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.98 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
10.08 | 18509659 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
10.08 | 15821434 17637181 15328337 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.57 | 17763956 10567023 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.81 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.88 | 11298111 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.53 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
marker/mechanism |
|
| 21472143 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.51 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
4.51 | 11005569 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
4.22 | 18641190 18395287 19196556 |
MESH:D005334 |
Fever |
|
Indomethacin |
8.85 | 10431976 11852909 17627676 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
8.85 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.85 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.42 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.72 | 10962813 |
MESH:D005355 |
Fibrosis |
|
Fructose |
14.14 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
14.14 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
14.14 | 19474275 |
MESH:D005414 |
Flatulence |
|
orlistat |
6.47 | 20002075 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
5.00 | 11298111 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
4.57 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.51 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
16.13 | 18405923 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
16.13 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
16.13 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
16.13 | 19804834 |
MESH:D005910 |
Glioma |
|
Indomethacin |
6.09 | 18371953 16487511 |
MESH:D005910 |
Glioma |
|
Quercetin |
6.09 | 17643826 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
4.15 | 11849393 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
5.16 | 19165636 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.88 | 7505956 |
MESH:D006073 |
Gout |
|
Indomethacin |
5.18 | 11248219 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.67 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
7.67 | 15482327 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.53 | 19566590 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.72 | 16879835 12587719 17875725 16330681 16495754 16244371 16707910 17888722 14766674 16144979 18674790 16244372 18006777 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
7.72 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.24 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.74 | 15692506 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.23 | 16366002 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
4.41 | 15633222 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.35 | 6705139 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.52 | 15135802 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.00 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
7.00 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
7.98 | 17434803 17043245 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
7.98 | 12727271 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.54 | 17883296 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.83 | 12524144 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.88 | 18262572 11834736 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.75 | 14757778 18563319 19008412 15752949 18360027 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
14.88 | 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
14.88 | 17546600 |
MESH:D006949 |
Hyperlipidemias |
|
orlistat |
14.88 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.77 | 15034207 |
MESH:D006973 |
Hypertension |
|
Fructose |
5.64 | 19008412 14633139 14568997 14573337 16843071 |
MESH:D006973 |
Hypertension |
|
Quercetin |
5.64 | 18356687 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.93 | 19799862 19342510 |
MESH:D007022 |
Hypotension |
|
Dopamine |
4.86 | 6740701 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.85 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
5.18 | 10651667 16133968 10647630 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
5.20 | 16133044 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.88 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
11.36 | 16956363 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.36 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
11.36 | 3291741 7812673 12568917 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
11.36 | 12878042 17255318 17237260 9205823 17963957 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.34 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
8.01 | 14633139 19799862 18563319 19008412 14573337 17133782 19586609 14757778 18057795 19342510 18981581 |
MESH:D007333 |
Insulin Resistance |
|
orlistat |
8.01 | 17201808 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
4.16 | 15831440 11686837 17329856 10210152 11713966 15610444 17994277 11855677 18236018 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
5.20 | 15241188 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.47 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.85 | 8074119 9022650 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.85 | 10574470 16133968 18306037 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.78 | 17086741 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
18.07 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
18.07 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
18.07 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
18.07 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
18.07 | 12093613 |
MESH:C531755 |
Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules |
|
orlistat |
6.47 | 17185156 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.00 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.83 | 6582329 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.76 | 11703811 12228301 10320625 |
MESH:D007938 |
Leukemia |
|
Quercetin |
3.07 | 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.98 | 16085563 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.80 | 10785260 16572323 15631656 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
2.61 | 18360721 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
5.20 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.54 | 17980183 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.53 | 15821434 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.54 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
orlistat |
4.26 | 17404856 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.09 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.89 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
4.89 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.89 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
4.89 | 12741479 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
3.22 | 16956363 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
4.59 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.59 | 15276417 16712894 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.35 | 598648 6587162 3712494 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.35 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
9.35 | 19519916 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.06 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.84 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.76 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
4.76 | 16537180 11497255 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
4.76 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.76 | 19931552 17306315 15276417 16712894 17077188 |
MESH:D008207 |
Lymphatic Metastasis |
|
orlistat |
5.72 | 20805790 18770866 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.34 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.65 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.40 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
2.92 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.17 | 16827129 |
MESH:D008545 |
Melanoma |
|
orlistat |
5.17 | 20805790 18770866 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.17 | 16487513 19082730 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.99 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.67 | 18497449 16815490 17261469 19165636 17098227 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.55 | 11903285 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.34 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
3.86 | 12636206 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.62 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
4.04 | 17505005 |
MESH:D009135 |
Muscular Diseases |
|
orlistat |
5.28 | 18430571 |
MESH:D009164 |
Mycobacterium Infections |
|
orlistat |
5.32 | 21442799 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.79 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.79 | 19595682 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
3.66 | 19207477 |
MESH:D009216 |
Myopia |
|
Atropine |
4.89 | 12601066 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.20 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.20 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
9.20 | 11239499 16537180 11053908 |
MESH:D009369 |
Neoplasms |
|
orlistat |
8.06 | 18710210 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
8.06 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.06 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
14.52 | 15625704 10663608 |
MESH:D009374 |
Neoplasms, Experimental |
|
orlistat |
14.52 | 19381703 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
14.52 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
orlistat |
5.17 | 17012255 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.60 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.85 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.89 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.89 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.18 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
3.80 | 12349958 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
10.41 | 17961222 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
10.41 | 17929310 |
MESH:C541083 |
Non-alcoholic Fatty Liver Disease |
|
orlistat |
5.40 | 17404856 |
MESH:D009765 |
Obesity |
marker/mechanism |
|
| |
MESH:D009765 |
Obesity |
|
Capsaicin |
7.68 | 19056576 |
MESH:D009765 |
Obesity |
|
Fructose |
7.68 | 17707055 18585860 |
MESH:D009765 |
Obesity |
|
orlistat |
7.68 | 19046740 21438711 16938137 18773755 20065556 20518802 19207292 21442799 20002075 20599501 19461584 20540997 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
5.00 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.27 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.85 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.56 | 7009135 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
4.06 | 19495926 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.98 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
4.85 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.85 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Capsaicin |
6.93 | 17084039 17434803 17043245 16996476 18987195 19081190 |
MESH:D010146 |
Pain |
|
Indomethacin |
6.93 | 17627676 3291741 17440234 13679232 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.51 | 12538197 18702446 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
2.79 | 16965848 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
8.53 | 15028970 17883296 |
MESH:D010195 |
Pancreatitis |
|
orlistat |
8.53 | 20065556 16938137 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.31 | 7296757 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.54 | 16537180 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.97 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.54 | 11903285 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.98 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.74 | 17225004 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.30 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.98 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.98 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.38 | 12224865 11605937 |
MESH:D011041 |
Poisoning |
|
Atropine |
4.99 | 18072136 17849254 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
orlistat |
5.14 | 17201808 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
3.83 | 19056647 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.96 | 17000239 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.72 | 16729912 16888761 15897917 16868541 18437689 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.72 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.72 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
4.00 | 11849393 |
MESH:D011629 |
Puberty, Precocious |
|
astressin B |
6.69 | 20002962 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.85 | 10930210 |
MESH:D012035 |
Refsum Disease |
|
orlistat |
5.90 | 20871815 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.05 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
3.88 | 18460982 19211983 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.62 | 10835634 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.25 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.84 | 15675481 16767912 17710206 15625365 18313854 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.08 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.62 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.37 | 16862918 |
MESH:D012640 |
Seizures |
|
Atropine |
6.66 | 17157343 12660363 11218047 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
6.66 | 9754883 10087439 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.66 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.66 | 18572023 19524636 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.40 | 15625365 17203757 16767912 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.66 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
4.25 | 18545984 10215738 10192188 17207306 17638125 15472012 16280098 15038085 18209964 16113693 16184426 10486359 17160473 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
3.14 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
orlistat |
3.14 | 19381703 |
MESH:D013276 |
Stomach Ulcer |
|
Atropine |
11.60 | 11595415 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
11.60 | 12077510 17135157 1323529 11595415 15104355 16252198 11906479 14567935 16150113 18726076 17627676 12500499 10750652 11145282 18431645 12498302 16631530 18087811 17977527 11595431 16755016 17654042 17918041 12467913 16397915 18193104 15138204 18209962 10423059 16169175 18181030 11729361 10878458 12787963 17895592 15255614 11523592 16934674 17657623 18237397 18543354 18299717 |
MESH:D013276 |
Stomach Ulcer |
|
olive oil |
11.60 | 12498302 16252198 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
4.83 | 9754883 11529278 |
MESH:D013610 |
Tachycardia |
|
Nitroprusside |
5.45 | 15306635 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.55 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.01 | 15821434 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.32 | 6582329 1399818 3712494 7505956 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.32 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
11.32 | 18791128 14736730 11352223 |
MESH:D014202 |
Tremor |
|
Atropine |
5.56 | 17594079 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.72 | 10574470 17380554 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.41 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.41 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
11.41 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.41 | 16452187 17306315 11723127 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.62 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.25 | 17056641 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.05 | 17638931 17334414 16364871 17678736 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.57 | 11897121 |